INTERNATIONAL MULTIDISCIPLINARY JOURNAL FOR
RESEARCH & DEVELOPMENT
SJIF 2019: 5.222 2020: 5.552 2021: 5.637 2022:5.479 2023:6.563 2024: 7,805
eISSN :2394-6334 https://www.ijmrd.in/index.php/imjrd Volume 12, issue 02 (2025)
410
THE INFLUENCE OF GENETIC FACTORS ON SUSCEPTIBILITY TO TUBERCULOSIS
Mirzakarimova Dildora Bakhodirovna
Department of Infectious Diseases
Andijan State Medical Institute
Abstract:
Tuberculosis (TB) remains a leading infectious cause of morbidity and mortality
worldwide. Although various environmental and socioeconomic factors contribute to TB risk, a
growing div of evidence highlights the importance of genetic predisposition in host susceptibility
to
Mycobacterium tuberculosis
infection [1]. This review summarizes current knowledge of the
genetic variants associated with increased or decreased TB risk, highlights emerging genomic and
transcriptomic approaches, and discusses the complex interplay between host genes and pathogen-
related factors [2]. Understanding these genetic determinants can facilitate personalized risk
assessments, inform vaccine development, and guide novel therapeutic strategies [3].
Keywords
: tuberculosis,
Mycobacterium tuberculosis
, genetics, susceptibility, immune response.
Introduction
Tuberculosis (TB) is caused by the bacterium
Mycobacterium tuberculosis
(Mtb), which typically
affects the lungs but can also infect other organs (extrapulmonary TB). Despite significant advances
in diagnostic tools and therapeutic regimens, TB remains a major global health challenge, with an
estimated 10.6 million new cases and 1.6 million deaths in 2021 alone 111.
Host defense against
M. tuberculosis
involves a coordinated immune response, primarily driven by
cell-mediated immunity involving T-cells and macrophages 222. However, not all individuals
exposed to Mtb become ill. While environmental and socioeconomic factors—such as overcrowding,
malnutrition, and HIV co-infection—can predispose a person to infection, host genetic variability
also plays a crucial role in determining whether infection progresses to active disease 333. This
article explores the main genetic factors that influence TB susceptibility and discusses emerging
directions for research [4].
Overview of Tuberculosis Susceptibility
The Role of the Immune Response
When Mtb enters the lungs, alveolar macrophages attempt to engulf and destroy the bacilli. A strong
cell-mediated immune response, orchestrated by CD4+^++ and CD8+^++ T-lymphocytes, is critical
for containing the pathogen within granulomas. However, certain genetic backgrounds may impair
or overly modulate immune responses, allowing Mtb to survive or replicate unchecked.
Population Genetics
It has long been observed that TB prevalence and severity vary among different population groups,
suggesting a hereditary component 444. Early twin studies demonstrated that monozygotic twins
have higher concordance rates of TB compared with dizygotic twins, supporting a genetic
contribution to host susceptibility.
Key Genetic Factors Associated with TB
NRAMP1 (SLC11A1)
One of the earliest and most widely studied genes implicated in TB susceptibility is
NRAMP1
(natural resistance-associated macrophage protein 1), also known as
SLC11A1
. This gene encodes a
divalent cation transporter in macrophages that influences intracellular microbial replication [5].
INTERNATIONAL MULTIDISCIPLINARY JOURNAL FOR
RESEARCH & DEVELOPMENT
SJIF 2019: 5.222 2020: 5.552 2021: 5.637 2022:5.479 2023:6.563 2024: 7,805
eISSN :2394-6334 https://www.ijmrd.in/index.php/imjrd Volume 12, issue 02 (2025)
411
Variations in NRAMP1 have been linked to altered control of intracellular pathogens, including Mtb,
with certain polymorphisms correlating with heightened TB risk 555.
HLA Class II Genes
The human leukocyte antigen (HLA) system, particularly the
HLA class II
genes (e.g., HLA-DR,
HLA-DQ), is central to antigen presentation. The specific HLA allele an individual carries can
affect how Mtb antigens are presented to T-lymphocytes. Certain HLA-DR and HLA-DQ variants
have been associated with either increased or reduced TB risk, indicating that immune recognition
of mycobacterial peptides can be genetically driven 666.
Cytokine Genes (IL-10, TNF-α, IFN-γ)
Cytokines are key mediators of the immune response against Mtb. Polymorphisms in cytokine genes
can modify immune signaling pathways. For instance:
IL-10
: Some variants lead to higher IL-10 production, potentially dampening the pro-
inflammatory response needed to clear Mtb.
TNF-α
: This cytokine is critical for granuloma formation. Genetic variants resulting in lower
TNF-α expression can impair granuloma maintenance.
IFN-γ
: Defects or downregulation in IFN-γ signaling diminish macrophage activation, thus
increasing TB susceptibility 777.
TLR (Toll-Like Receptor) Genes
Toll-like receptors are essential for pathogen recognition.
TLR2
,
TLR4
, and
TLR9
have been
studied in the context of TB. Mutations that alter TLR signaling can reduce the immune system’s
ability to sense and respond to Mtb, leading to an increased risk of developing active disease 888.
VDR (Vitamin D Receptor)
Vitamin D plays an immunomodulatory role, particularly in macrophage activation and the
production of antimycobacterial peptides (such as cathelicidin). Variations in the
vitamin D
receptor (VDR)
gene can affect an individual’s ability to mount an effective immune response
against Mtb. Several studies have demonstrated an association between certain VDR polymorphisms
and increased TB susceptibility, although these findings can vary by ethnic group 999.
Genetic Approaches and Emerging Research
Genome-Wide Association Studies (GWAS)
GWAS has become a powerful tool to identify novel genetic loci associated with TB risk [6]. By
scanning the entire genome in large populations, GWAS can uncover candidate genes and pathways
that were not previously linked to TB. Several GWAS have highlighted regions on chromosomes 8q,
11p, and 18q, suggesting new avenues for research 101010.
Transcriptomic and Epigenetic Studies
Transcriptomics
: Examines gene expression profiles of infected versus non-infected
individuals to reveal specific immunological signatures associated with TB resistance or progression.
Epigenetics
: Factors such as DNA methylation and histone modification can modulate
immune gene expression without altering the underlying DNA sequence [7]. Epigenetic changes
may help explain variable responses among individuals with similar genetic backgrounds 111111.
Host-Directed Therapies
INTERNATIONAL MULTIDISCIPLINARY JOURNAL FOR
RESEARCH & DEVELOPMENT
SJIF 2019: 5.222 2020: 5.552 2021: 5.637 2022:5.479 2023:6.563 2024: 7,805
eISSN :2394-6334 https://www.ijmrd.in/index.php/imjrd Volume 12, issue 02 (2025)
412
Understanding the host genetic factors that modulate TB susceptibility paves the way for
host-
directed therapies
. These strategies aim to boost the patient’s immune response or correct
genetic/epigenetic deficiencies [6]. For instance, targeting pathways governed by IFN-γ or TNF-α
might enhance granuloma formation and bacterial clearance, potentially improving treatment
outcomes when combined with standard anti-TB drugs.
Clinical Implications
1.
Personalized Medicine
: Genetic screening could identify individuals at higher risk,
allowing for tailored preventive strategies (e.g., prophylactic treatment, enhanced monitoring).
2.
Vaccine Development
: Knowledge of protective genetic variants could guide the design of
more effective vaccines or adjuvants to bolster specific immune pathways.
3.
Public Health Strategies
: Incorporating genetic data into TB control programs may
improve resource allocation, focusing interventions in high-risk populations.
Despite these promising avenues, there is a need for large-scale, multi-ethnic studies to replicate
findings and ensure that identified genetic markers have consistent predictive value [8]. Additionally,
ethical considerations, such as genetic privacy and the potential stigmatization of high-risk groups,
must be carefully addressed.
6. Conclusions
Genetic factors play a critical role in modulating host susceptibility to
Mycobacterium tuberculosis
.
Variants in NRAMP1, HLA genes, cytokine genes, TLRs, and VDR, among others, can influence
the immune response, shaping an individual’s risk profile [9]. Emerging genomic and transcriptomic
approaches are shedding light on previously unknown pathways and gene-environment interactions.
Moving forward, integrating genetic insights into clinical practice will require well-designed,
ethically sound research, coupled with robust public health policies [10]. By unraveling the genetic
underpinnings of TB susceptibility, clinicians and researchers can develop better prevention,
diagnostic, and therapeutic strategies to combat this persistent global health threat.
References
1.
World Health Organization. Global Tuberculosis Report 2022. Available from:
2.
Dheda K, Barry CE III, Maartens G. Tuberculosis. Lancet. 2016;387(10024):1211-1226.
3.
Bakhodirovna, Mirzakarimova Dildora, and Abdukodirov Sherzodjon Taxirovich.
"CHARACTERISTICS OF RHINOVIRUS INFECTION." International journal of medical sciences
4, no. 08 (2024): 55-59.
4.
Mirzakarimova, D. B., Hodjimatova, G. M., & Abdukodirov, S. T. (2024). FEATURES OF
PATHOGENESIS, CLINICAL PICTURE AND DIAGNOSIS OF CO-INFECTION OF THE
LIVER WITH HEPATITIS B AND C VIRUSES. International Multidisciplinary Journal for
Research & Development, 11(02).
5.
Nikolaevna, Solomonnik Oksana. "CLINIC OF THE INITIAL PERIOD OF
SALMONELLASIS CAUSED BY SALMONELLA TYPHIMURIUM IN CHILDREN."
International Multidisciplinary Journal for Research & Development 11, no. 01 (2024).
INTERNATIONAL MULTIDISCIPLINARY JOURNAL FOR
RESEARCH & DEVELOPMENT
SJIF 2019: 5.222 2020: 5.552 2021: 5.637 2022:5.479 2023:6.563 2024: 7,805
eISSN :2394-6334 https://www.ijmrd.in/index.php/imjrd Volume 12, issue 02 (2025)
413
6.
Юлдашев, Я. М., and М. М. Юнусов. "ВЛИЯНИЕ БАРБАРИСА ОБЫКНОВЕННОГО
НА АУТОКОАГУЛЯЦИОННЫЙ ТЕСТ КРОВИ БОЛЬНЫХ ВИРУСНЫМ ГЕПАТИТОМ В."
Экономика и социум 11-1 (102) (2022): 1269-1274.
7.
Gulamovich, Djurayev Muzaffar, and Kaxarov Abdukaxar Nabijonovich. "CHANGES IN
THE FUNCTIONAL STATE OF THE THYROID GLAND IN CHILDREN WITH BRONCHIAL
ASTHMA." International Multidisciplinary Journal for Research & Development 11, no. 01 (2024).
8.
Zaynobidin o’g’li, Sotvoldiyev Muzaffar. "MEASURES TO FIGHT THE EPIDEMIC."
Ethiopian International Journal of Multidisciplinary Research 11, no. 03 (2024): 261-263.
9.
Yakubova, Ranohon Maksimovna. "CLINICAL COURSE OF VIRAL HEPATITIS B, C,
AND D IN PATIENTS WITH HEMATOLOGICAL PATHOLOGY." World of Scientific news in
Science 2, no. 3 (2024): 65-69.
10.
Ernst JD. The immunological life cycle of tuberculosis. Nat Rev Immunol. 2012;12(8):581-
591.
